V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis

被引:17
|
作者
Schliebe, Nicole [1 ]
Strotmann, Rainer [1 ]
Busse, Kathy [1 ]
Mitschke, Doreen [1 ]
Biebermann, Heike [2 ]
Schomburg, Lutz [3 ]
Koehrle, Josef [3 ]
Baer, Jorg [1 ]
Roempler, Holger [1 ]
Wess, Juergen [4 ]
Schoeneberg, Torsten [1 ]
Sangkuhl, Katrin [1 ]
机构
[1] Univ Leipzig, Fac Med, Inst Biochem, D-04103 Leipzig, Germany
[2] Humboldt Univ, Fac Med, Charite, Inst Expt Pediat Endocrinol, Berlin, Germany
[3] Humboldt Univ, Fac Med, Charite, Inst Expt Endocrinol, Berlin, Germany
[4] NIDDK, Bioorgan Chem Lab, Natl Inst Hlth, Bethesda, MD 20892 USA
关键词
vasopressin receptor; diabetes insipidus; G protein-coupled receptor; signal transduction; hypernatremia;
D O I
10.1152/ajprenal.00465.2007
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Polyuria, hypernatremia, and hypovolemia are the major clinical signs of inherited nephrogenic diabetes insipidus (NDI). Hypernatremia is commonly considered a secondary sign caused by the net loss of water due to insufficient insertion of aquaporin-2 water channels into the apical membrane of the collecting duct cells. In the present study, we employed transcriptome-wide expression analysis to study gene expression in V2 vasopressin receptor (Avpr2)-deficient mice, an animal model for X-linked NDI. Gene expression changes in NDI mice indicate increased proximal tubular sodium reabsorption. Expression of several key genes including Na+-K+-ATPase and carbonic anhydrases was increased at the mRNA levels and accompanied by enhanced enzyme activities. In addition, altered expression was also observed for components of the eicosanoid and thyroid hormone pathways, including cyclooxygenases and deiodinases, in both kidney and hypothalamus. These effects are likely to contribute to the clinical NDI phenotype. Finally, our data highlight the involvement of the renin-angiotensin-aldosterone system in NDI pathophysiology and provide clues to explain the effectiveness of diuretics and indomethacin in the treatment of NDI.
引用
收藏
页码:F1177 / F1190
页数:14
相关论文
共 50 条
  • [21] ATTENUATION OF VASOPRESSIN VASOCONSTRICTOR ACTION BY V2 RECEPTOR STIMULATION IN THE RENAL MEDULLARY CIRCULATION
    NAKANISHI, K
    MATTSON, DL
    GROSS, V
    COWLEY, AW
    HYPERTENSION, 1993, 22 (03) : 445 - 445
  • [22] Downregulation of the V2 vasopressin receptor in dehydration: mechanisms and role of renal prostaglandin synthesis
    Machida, Kenji
    Wakamatsu, Shiho
    Izumi, Yuichiro
    Yosifovska, Tatjana
    Matsuzaki, Takanobu
    Nakayama, Yushi
    Kohda, Yukimasa
    Inoue, Takeaki
    Saito, Hideyuki
    Tomita, Kimio
    Nonoguchi, Hiroshi
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (04) : F1274 - F1282
  • [23] PHOTOAFFINITY-LABELING OF THE RENAL V2 VASOPRESSIN RECEPTOR - IDENTIFICATION AND ENRICHMENT OF A VASOPRESSIN-BINDING SUBUNIT
    FAHRENHOLZ, F
    BOER, R
    CRAUSE, P
    TOTH, MV
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (03): : 589 - 595
  • [24] AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus
    Wildin, RS
    Cogdell, DE
    Valadez, V
    KIDNEY INTERNATIONAL, 1998, 54 (06) : 1909 - 1922
  • [25] Effect of mutations in putative hormone binding sites on V2 vasopressin receptor function
    Sebti, Y.
    Rabbani, M.
    Sadeghi, H. Mir Mohammad
    Sardari, S.
    Ghahremani, M. H.
    Innamorati, G.
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2015, 10 (03) : 259 - 267
  • [26] Expression and detection of human vasopressin V2 receptor in a polarized epithelial cell line
    Andersen-Beckh, B
    Liebenhoff, U
    Wiesner, B
    Rosenthal, W
    Oksche, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R650 - R650
  • [27] Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct
    Khan, Shaza
    Raghuram, Viswanathan
    Chen, Lihe
    Chou, Chung-Lin
    Yang, Chin-Rang
    Khundmiri, Syed J.
    Knepper, Mark A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 326 (01) : F57 - F68
  • [28] Increased renal responsiveness to vasopressin and enhanced V2 receptor signaling in RGS2-/- mice
    Zuber, Annie Mercier
    Singer, Dustin
    Penninger, Josef M.
    Rossier, Bernard C.
    Firsov, Dmitri
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1672 - 1678
  • [29] Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis
    Erdelyi, Laszlo S.
    Mann, W. Alexander
    Morris-Rosendahl, Deborah J.
    Gross, Ute
    Nagel, Mato
    Varnai, Peter
    Balla, Andras
    Hunyady, Laszlo
    KIDNEY INTERNATIONAL, 2015, 88 (05) : 1070 - 1078
  • [30] Phosphoproteomic identification of vasopressin V2 receptor-dependent signaling in the renal collecting duct
    Deshpande, Venkatesh
    Kao, Anika
    Raghuram, Viswanathan
    Datta, Arnab
    Chou, Chung-Lin
    Knepper, Mark A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (04) : F789 - F804